The popularity of health apps raises significant issues in terms of patient privacy. HIPAA rules apply when protected (PHI) ...

Topline results were announced from a phase 3 trial evaluating icotrokinra in patients with moderate to severe plaque psoriasis (PsO).

Risankizumab had greater improvements in skin clearance and quality of life at 16 weeks in patients with psoriasis compared with deucravacitinib.

Osteoporosis is highly prevalent among postmenopausal women with SSc and was associated with impaired QOL and worse PROs.

Seasonal maternal respiratory syncytial virus vaccination and nirsevimab for infants demonstrate cost-effectiveness.

Based on the current trajectory, overweight and obesity will continue increasing in the United States up to 2050.

COVID-19, influenza, and respiratory syncytial virus vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).

To run the U.S. Centers for Disease Control and Prevention, Trump has turned to David Weldon, M.D., a long-time internist who interrupted his medical career to represent a Florida district for seven ...

More than half of all US adults are eligible for semaglutide therapy, according to a research letter published in JAMA Cardiology to coincide with the AHA Scientific Sessions 2024.

Women with a history of endometriosis and uterine fibroids may have an increased risk of premature mortality, according to a study published online Nov. 20 in T ...

Apremilast (APR) shows significant efficacy and safety over 48 weeks for the management of early oligoarticular psoriatic arthritis (PsA), according to study results presented at the American College ...